|
Jun 26
|
Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?
|
|
Jun 26
|
Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies
|
|
Jun 26
|
2 Stocks Too Cheap to Ignore at These Prices
|
|
Jun 25
|
Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT
|
|
Jun 25
|
Will New Drugs Enable BMY to Offset the Impact of Generic Competition?
|
|
Jun 25
|
Merck Moves Past 50-Day Average: How to Play MRK Stock Now
|
|
Jun 25
|
Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged
|
|
Jun 25
|
2 Cash-Producing Stocks for Long-Term Investors and 1 to Think Twice About
|
|
Jun 24
|
Jefferies Reaffirms Merck (MRK) ‘Buy’ Rating on Gardasil Dosing Stability
|
|
Jun 24
|
MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal
|
|
Jun 24
|
Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?
|
|
Jun 24
|
Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?
|
|
Jun 24
|
EXEL Stock Rises on Positive Data From Colorectal Cancer Study
|
|
Jun 24
|
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
|
|
Jun 24
|
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
|
|
Jun 24
|
Brain Cancer Market Research Report 2025-2035 | Growing Shifts Toward Targeted Therapies and Immunotherapy Over Traditional Methods
|
|
Jun 24
|
Allergic Rhinitis Market Report 2025-2035 | Innovative Drug Classes and Regional Trends Propel Expansion
|
|
Jun 24
|
Merck Poised to Deliver Strong Results and Steady Dividend Growth
|
|
Jun 23
|
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)
|
|
Jun 20
|
The 5 Most Interesting Analyst Questions From Merck’s Q1 Earnings Call
|